Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Beijing China (1991)
Status: No NME R&D (1991)

Organization Overview

First Clinical Trial
2007
NCT01014845
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | Xiamen Innovax Biotech Co., Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma in Situ (Phase 3)

Cervical Intraepithelial Neoplasia (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis E (Phase 4)

Neoplasms (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial APIs: 6